From July 5, 2023 to July 11, 2023, the company has repurchased 1,121,900 shares, representing 0.25% for CNY 30.1 million. With this, the company has completed the repurchase of 1,121,900 shares, representing 0.25% for CNY 30.1 million under the buyback announced on July 5, 2023.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.7 CNY | -0.48% | +20.81% | -11.50% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.50% | 1.73B | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.3B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-5.02% | 1.64B | |
-8.80% | 1.53B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on July 5, 2023.